Azienda Ospedaliera di Padova

2 trials 1 recruiting Academic / non-commercial

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

1 Countries active

2 Unique IMPs

100% Results reported

Phase II

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

CLENBUTEROL HYDROCHLORIDE 1 ZANUBRUTINIB 1

All trials

2 total

Zanubritnib and anti-MAG neuropathy Recruiting

2025-523091-23-00 Phase II 1 country ZANUBRUTINIB
A Placebo-controlled Study to Evaluate the Efficacy and Safety of Clenbuterol in Patients with Spinal and Bulbar Muscular Atrophy (SBMA) Ended

2024-516563-86-00 Phase II 1 country CLENBUTEROL HYDROCHLORIDE

Showing 1–2 of 2 trials

← All sponsors A–Z